Jupiter Neurosciences, Inc. (JUNS)

NASDAQ

$2.82

$-0.16

(-5.21%)

Pre-Market

Jupiter Neurosciences, Inc. (JUNS) Live Price Chart

Last updated: ⁦2026-10-13 09:20:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Jupiter Neurosciences, Inc. (JUNS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.82, with a market capitalisation of $3.76M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.25 to $135.75. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.76M
Open	$2.98
Day's High	$1,463.25
Day's Low	$2.25
Previous Close	$3.04
Volume	651.00
Average Volume	999.49K
P/E Ratio	--
52-Week High	$135.75
52-Week Low	$2.25
Dividend Yield	--
Earnings Date	--

Jupiter Neurosciences, Inc. (JUNS) Pre-Market Stock Price

Jupiter Neurosciences, Inc. (JUNS) is trading at $2.82 in pre-market trading as of 2026-10-13 08:20:00, down 7.24% ($0.22) from the previous close of $3.04

Pre-market trading shows how investors are pricing JUNS before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Jupiter Neurosciences, Inc. (JUNS) 7-Day Stock Price Change

Over the past seven days, Jupiter Neurosciences, Inc. (JUNS) moved from $2.55 to $2.82, representing a gain of 10.59% ($0.27).

The stock traded between $2.25 and $3.18 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 154.66 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

JUNS 52-Week Price Position

Position in Range: 0.4%

52W Low$2.25

52W High$135.75

JUNS is currently trading at $2.82, placing it 0.4% of the way from its 52-week low of $2.25 to its 52-week high of $135.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Jupiter Neurosciences, Inc. (JUNS)?

Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.

Jupiter Neurosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.jupiterneurosciences.com

How to Buy Jupiter Neurosciences, Inc. (JUNS) Stock on MEXC

Eligible investors can buy real shares of Jupiter Neurosciences, Inc. (JUNS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for JUNS and Place Your Order

Open the RealStocks trading page and search for JUNS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Jupiter Neurosciences, Inc. (JUNS) stock price today?

Jupiter Neurosciences, Inc. (JUNS) is currently trading at $ 2.82, down 7.24% ($0.22) from the previous close of $ 3.04. Intraday prices update in real time during regular trading hours.

2.Is JUNS stock going up or down today?

As of 2026-10-13 08:20:00, JUNS is trading at $ 2.82, down 7.24% ($0.22) from its previous close of $ 3.04. The stock has traded between $ 2.25 and $ 1,463.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is JUNS pre-market price?

As of 2026-10-13 08:20:00, JUNS is trading at $ 2.82 in pre-market trading, down 7.24% ($0.22) from the previous close of $ 3.04. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is JUNS after-hours price?

As of 2026-10-13 08:20:00, JUNS is trading at $ 2.98 in after-hours trading, down 2.14% ($0.06) from the regular-session close of $ 3.04. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is JUNS stock trading now?

JUNS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does JUNS sit relative to its 52-week high and low?

Over the past 52 weeks, JUNS has traded between a low of $ 2.25 and a high of $ 135.75. At $ 2.82, the stock is positioned 0.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Jupiter Neurosciences, Inc. in?

Jupiter Neurosciences, Inc. (JUNS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Jupiter Neurosciences, Inc.'s market capitalisation and where is it listed?

Jupiter Neurosciences, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 3.76M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is JUNS valued in terms of P/E ratio and EPS?

JUNS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -6.98. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Jupiter Neurosciences, Inc. pay a dividend?

Jupiter Neurosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.